Format
Sort by

Send to

Choose Destination

Search results

Items: 10

1.

The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis.

Zivadinov R, Dwyer MG, Ramasamy DP, Davis MD, Steinerman JR, Khan O.

J Neuroimaging. 2015 Nov-Dec;25(6):989-95. doi: 10.1111/jon.12293.

2.

GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40 mg three-times weekly versus 20 mg daily in patients with relapsing-remitting multiple sclerosis.

Wolinsky JS, Borresen TE, Dietrich DW, Wynn D, Sidi Y, Steinerman JR, Knappertz V, Kolodny S; GLACIER Study Group..

Mult Scler Relat Disord. 2015 Jul;4(4):370-6. doi: 10.1016/j.msard.2015.06.005.

3.

Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense "black holes": a post hoc magnetic resonance imaging analysis.

Zivadinov R, Dwyer M, Barkay H, Steinerman JR, Knappertz V, Khan O.

J Neurol. 2015 Mar;262(3):648-53. doi: 10.1007/s00415-014-7616-0.

PMID:
25542295
4.

Nonmelanoma skin cancer is associated with reduced Alzheimer disease risk.

White RS, Lipton RB, Hall CB, Steinerman JR.

Neurology. 2013 May 21;80(21):1966-72. doi: 10.1212/WNL.0b013e3182941990.

5.

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.

Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM, Seibyl J, Reininger C, Sabri O; Florbetaben Study Group..

Lancet Neurol. 2011 May;10(5):424-35. doi: 10.1016/S1474-4422(11)70077-1.

PMID:
21481640
6.

Training cognitive control in older adults with the space fortress game: the role of training instructions and basic motor ability.

Blumen HM, Gopher D, Steinerman JR, Stern Y.

Front Aging Neurosci. 2010 Nov 11;2:145. doi: 10.3389/fnagi.2010.00145.

7.

Modeling cognitive trajectories within longitudinal studies: a focus on older adults.

Steinerman JR, Hall CB, Sliwinski MJ, Lipton RB.

J Am Geriatr Soc. 2010 Oct;58 Suppl 2:S313-8. doi: 10.1111/j.1532-5415.2010.02982.x. Review.

8.

Minding the aging brain: technology-enabled cognitive training for healthy elders.

Steinerman JR.

Curr Neurol Neurosci Rep. 2010 Sep;10(5):374-80. doi: 10.1007/s11910-010-0124-4. Review.

PMID:
20544402
9.

Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study.

Steinerman JR, Irizarry M, Scarmeas N, Raju S, Brandt J, Albert M, Blacker D, Hyman B, Stern Y.

Arch Neurol. 2008 Jul;65(7):906-12. doi: 10.1001/archneur.65.7.906.

10.

Laboratory biomarkers in Alzheimer's disease.

Steinerman JR, Honig LS.

Curr Neurol Neurosci Rep. 2007 Sep;7(5):381-7. Review.

PMID:
17764627
Items per page

Supplemental Content

Loading ...
Support Center